Insiders · ASRT

William Mckee

Director at Assertio Holdings, Inc. (ASRT)

William Mckee has filed 11 insider reports with the SEC since May 2021, as director at Assertio Holdings, Inc. (ASRT) and director at Aileron Therapeutics Inc (RNTX). William Mckee made no open-market purchases or sales in the last 12 months. The latest filing, on June 16, 2026, reports sale back to the company and tender of shares in a change of control at Assertio Holdings, Inc. (ASRT).

Filings
11
Companies
2
Bought on market
None
Sold on market
$122K

Companies where William Mckee is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Assertio Holdings, Inc. logo
ASRT
Assertio Holdings, Inc.
Director0$122KJun 16, 2026
Aileron Therapeutics Inc logo
RNTX
Aileron Therapeutics Inc
Director$0.3677Jun 17, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare William Mckee with

Other insiders at the same companies

Questions about William Mckee

What is William Mckee's role at Assertio Holdings, Inc.?
William Mckee reports to the SEC as director at Assertio Holdings, Inc. (ASRT), according to the latest filing on June 16, 2026. William Mckee has also filed as director at Aileron Therapeutics Inc (RNTX).
Has William Mckee bought or sold stock recently?
The most recent open-market sale was on August 14, 2023: sold 22,000 shares of Assertio Holdings, Inc. (ASRT) for $69K at an average of $3.14.
How do I get alerts when William Mckee files?
Follow William Mckee on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by William Mckee (SEC CIK 0001237262). Totals count each trade once, skipping amendments whose original is on file, from May 13, 2021 on. View on SEC EDGAR · Get this as JSON